118
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

In Vitro Study of the Effect of 2,6-Substituents at the New 4-Ethoxy-Phenols as Antioxidants

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 790-800 | Received 21 Apr 2021, Accepted 07 Dec 2021, Published online: 27 Dec 2021
 

Abstract

The antioxidant effect of the different groups in the 2,6-positions of the new 4-ethoxy-phenols were evaluated. To address our research, 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2’-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) and reducing power capacity, were employed to analyze the antioxidant activity. The results of the antioxidant test indicated that most of the new molecules 6a–l presented high antioxidant activity. Compound 6f had the highest activity (1.47 ± 0.39 µg/mL) when it was compared with 2,6 di-tert-butyl hydroxytoluene (BHT, 6.72 ± 0.47 µg/mL) and trolox (2.81 ± 0.31 µg/mL) as standards using DPPH assay. ABTS method confirmed that 6f was the most active antioxidant molecule. Theoretical analysis showed that phenyl group in 6f has a similar effect in the O-H energy that t-butyl in BHA, but the steric hindrance is different. In the three tests, compound 6i turned out to be the one with the least antioxidant effect; it demonstrated the main role of hydroxyl group on the topology of the species to achieve the desired antioxidant effect, which was completely lost when this group was absent.

Acknowledgments

The authors appreciate of the Guanajuato National Laboratory (UG-UAA-CONACyT (#123732) for their generous allocation of analytical and computing resources. J.E.R.C. and I.V.C. acknowledge CONACyT for a graduate scholarship (#475857 and #926323, respectively). A.F. acknowledge CONACyT for a postdoctoral grant #472610.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

Consejo Nacional de Ciencia y Tecnología by the CONACyT under Grant A1-S-27694 and DAIP-UG under Grant 034/2021.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.